REVUMENIB SESQUIFUMARATE

SynDRA canonical compound SYN0040124 — structure-anchored drug synonym record

Clinical phase	Phase 1
Primary target(s)	KMT2A \| MEN1
Indication	acute myeloid leukemia (aml)
Disease area	hematologic malignancy

All known targets

KMT2A
MEN1
MEN1-KMT2A

Mechanisms of action (all sources)

Inhibitor

Cross-references

PubChem CID: 132212657
ChEMBL: CHEMBL4650278
TTD: D97YGW

Synonyms

Sndx-5613
SNDX-50613
SNDX50613
SNDX5613
SNDX-5613
SCHEMBL19693219
SCHEMBL19693428
EX-A4343
NSC825775
NSC-825775
HY-136175
CS-0120274

Look up REVUMENIB SESQUIFUMARATE in the interactive SynDRA portal →